Sangamo Therapeutics Inc (SGMO) Insider Trading
- $45,174,920.90
- $83,310,269.06
- Sept. 26, 2023
- Ra Capital Management, Llc
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Feb. 1, 2018 | Director | 11,520 | $20.59 | Sell | $237,196.80 | |
Jan. 8, 2018 | VP | 5,000 | $17.11 | Sell | $85,550.00 | |
Jan. 3, 2018 | VP | 15,000 | $17.26 | Sell | $258,900.00 | |
Dec. 6, 2017 | VP | 5,000 | $16.24 | Sell | $81,200.00 | |
Dec. 4, 2017 | VP | 11,803 | $18.00 | Sell | $212,454.00 | |
Dec. 1, 2017 | VP | 16,630 | $16.13 | Sell | $268,241.90 | |
Nov. 17, 2017 | Director | 5,000 | $14.67 | Sell | $73,350.00 | |
Oct. 2, 2017 | VP | 15,000 | $15.25 | Sell | $228,750.00 | |
Sept. 20, 2017 | Director | 31,000 | $14.37 | Sell | $445,470.00 | |
Sept. 1, 2017 | VP | 15,000 | $15.00 | Sell | $225,000.00 | |
Aug. 14, 2017 | VP | 11,474 | $10.44 | Sell | $119,788.56 | |
July 14, 2017 | VP | 15,000 | $10.00 | Sell | $150,000.00 | |
June 1, 2017 | VP | 2,000 | $6.80 | Sell | $13,600.00 | |
May 12, 2017 | VP | 2,639 | $8.02 | Sell | $21,164.78 | |
Aug. 1, 2015 | Major Shareholder | 27,770 | $12.82 | Sell | $356,011.40 | |
July 30, 2015 | Major Shareholder | 109,590 | $12.42 | Sell | $1,361,107.80 | |
July 29, 2015 | Major Shareholder | 1,407 | $12.41 | Sell | $17,460.87 | |
July 28, 2015 | Major Shareholder | 60,081 | $12.11 | Sell | $727,580.91 | |
July 25, 2015 | Major Shareholder | 47,429 | $12.31 | Sell | $583,850.99 | |
July 24, 2015 | Major Shareholder | 124,050 | $12.28 | Sell | $1,523,334.00 | |
July 17, 2015 | Major Shareholder | 37,215 | $12.26 | Buy | $456,255.90 | |
July 15, 2015 | CEO | 25,000 | $10.43 | Sell | $260,750.00 | |
July 13, 2015 | CFO | 12,000 | $10.00 | Sell | $120,000.00 | |
July 1, 2015 | Major Shareholder | 82,700 | $16.01 | Sell | $1,324,027.00 | |
June 16, 2015 | Major Shareholder | 250,500 | $16.55 | Sell | $4,145,775.00 | |
June 9, 2015 | Major Shareholder | 83,500 | $15.50 | Sell | $1,294,250.00 | |
June 6, 2015 | Major Shareholder | 135,101 | $14.29 | Sell | $1,930,593.29 | |
June 5, 2015 | Major Shareholder | 115,102 | $14.13 | Sell | $1,626,391.26 | |
June 5, 2015 | CMO | 15,000 | $12.29 | Sell | $184,350.00 | |
June 4, 2015 | Major Shareholder | 70,640 | $13.10 | Sell | $925,384.00 | |
June 3, 2015 | Major Shareholder | 76,833 | $12.86 | Sell | $988,072.38 | |
June 3, 2015 | Director | 2,200 | $12.44 | Sell | $27,368.00 | |
June 1, 2015 | SVP | 15,000 | $12.39 | Sell | $185,850.00 | |
May 30, 2015 | Major Shareholder | 65,884 | $13.40 | Sell | $882,845.60 | |
May 29, 2015 | Major Shareholder | 155,675 | $13.53 | Sell | $2,106,282.75 | |
May 28, 2015 | Major Shareholder | 148,689 | $13.43 | Sell | $1,996,893.27 | |
May 27, 2015 | Major Shareholder | 263,437 | $13.55 | Sell | $3,569,571.35 | |
May 23, 2015 | Major Shareholder | 51,597 | $13.27 | Sell | $684,692.19 | |
May 22, 2015 | Major Shareholder | 56,396 | $13.56 | Sell | $764,729.76 | |
May 13, 2015 | Major Shareholder | 56,060 | $13.12 | Sell | $735,507.20 | |
May 12, 2015 | Major Shareholder | 29,659 | $13.03 | Sell | $386,456.77 | |
May 8, 2015 | Major Shareholder | 83,300 | $12.40 | Sell | $1,032,920.00 | |
May 7, 2015 | Major Shareholder | 35,736 | $12.09 | Buy | $432,048.24 | |
May 5, 2015 | CMO | 15,000 | $12.29 | Sell | $184,350.00 | |
May 4, 2015 | Director | 3,000 | $12.98 | Sell | $38,940.00 | |
April 30, 2015 | Major Shareholder | 124,500 | $13.45 | Buy | $1,674,525.00 | |
April 28, 2015 | Major Shareholder | 74,844 | $13.29 | Buy | $994,676.76 | |
April 25, 2015 | Major Shareholder | 166,000 | $13.63 | Buy | $2,262,580.00 | |
April 22, 2015 | Major Shareholder | 352,750 | $14.86 | Sell | $5,241,865.00 | |
April 17, 2015 | Major Shareholder | 41,500 | $14.02 | Buy | $581,830.00 |
Insiders are both buying and selling Sangamo Therapeutics Inc stock.
The insider traders at Sangamo Therapeutics Inc are: Ra Capital Management, Llc, Henry Ward Wolff, Kathy Yi, Philip D Gregory, Edward R. Conner, Dale G Ando, Edward O Lanphier II, Curt A Herberts III, John William Larson, William R Ringo, Edward Lanphier II, Biogen Inc., Saira Ramasastry, Dale Ando, Philip Gregory, H Stewart Parker, Curt A. Herberts III, Steven J Mento, Paul B Cleveland, Joseph S. Zakrzewski, Steven Mento, Rolf Andrew Ramelmeier, Gary Loeb, Stephen George Dilly, John Markels, Edward R Conner, and Paul Cleveland
The most active insider trader at Sangamo Therapeutics Inc is Ra Capital Management, Llc with 67 trades.
Ra Capital Management, Llc has sold the most Sangamo Therapeutics Inc stock with a total value of $51,828,744.34.
Ra Capital Management, Llc has bought the most Sangamo Therapeutics Inc stock with a total value of $45,450,853.84.
The most recent insider trade for Sangamo Therapeutics Inc was on Sept. 26, 2023.
The single biggest insider buy for Sangamo Therapeutics Inc was from Ra Capital Management, Llc with a total value of $5,748,888.25 on March 7, 2015.
The single biggest insider sell for Sangamo Therapeutics Inc was from Ra Capital Management, Llc with a total value of $5,241,865.00 on April 22, 2015.